CSE Global: CIMB maintains OutPerform with TP of $1.71, based on 12x CY11 P/E. Note that in recent Co. visit, gained insights into management’s vision for the company, where it sees the most attractive opportunities and its strategic roadmap to attain its goals….
Expect CSE’s earnings growth to be underpinned by opportunities in the UK healthcare sector and higher contributions from the Middle East and Australia. now, still based on 12x See additional stock catalysts from higher-than-expected orders and accretive acquisitions.
No comments:
Post a Comment